Document is current
Any future updates will be listed below
-
Authors
He, Jia https://orcid.org/0000-0003-0483-4320
Wang, Chaoyu https://orcid.org/0000-0001-9224-5061
Fang, Xiao
Li, Junyao
Shen, Xueying
Zhang, Junxia
Peng, Cheng
Li, Hongjian
Li, Sai https://orcid.org/0000-0002-9353-0355
Karp, Jeffrey M. https://orcid.org/0000-0002-4752-7374
Kuai, Rui https://orcid.org/0000-0003-2324-1272
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (32241031, 32171195)
- License Information
-
More Information
Article History
Received: 15 August 2023
Accepted: 27 August 2024
First Online: 16 September 2024
Competing interests
: A patent application (2023100745723) has been filed based on the ultrasound-responsive liposomal nanovaccines for simultaneously programing the expansion and intratumoral infiltration of T cells, with R.K., J.H. and C.W. as inventors. J.M.K has been a paid consultant and or equity holder for companies (listed here: ). J.M.K. is a paid consultant and holds equity in Corner Therapeutics, a company that has licensed IP generated by J.M.K. that may benefit financially if the IP is further validated. R.K. holds equity in Corner Therapeutics. The interests of J.M.K. were reviewed and are subject to a management plan overseen by his institutions in accordance with its conflict of interest policies. The remaining authors declare no competing interests.
